Diphenylhydantoin-induced lymphocytic interstitial pneumonia

Chest. 1986 Sep;90(3):458-60. doi: 10.1378/chest.90.3.458.

Abstract

A patient developed diffuse lymphocytic interstitial pneumonia after receiving diphenylhydantoin therapy for 14 months. Withdrawal of medication resulted in reversal of the disease process. This case illustrates the value of combined transbronchial biopsy and bronchoalveolar lavage sampling in establishing a diagnosis, and the utility of serial bronchoalveolar lavage in monitoring disease evolution.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Bronchi / pathology
  • Epilepsy, Temporal Lobe / drug therapy
  • Female
  • Humans
  • Phenytoin / adverse effects*
  • Phenytoin / therapeutic use
  • Pulmonary Alveoli / pathology
  • Pulmonary Fibrosis / chemically induced*
  • Pulmonary Fibrosis / pathology
  • Therapeutic Irrigation

Substances

  • Phenytoin